Lung cancer Follow-Up study ends early – only 5 participants

NCT ID NCT06654245

Terminated Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tested a program called SHAREDCare, where a navigator helps lung cancer survivors identify their needs and create a plan to address them. The goal was to improve follow-up care after cancer treatment. However, the study was terminated early and included only 5 people, so it provides very limited information.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SHAREDCare navigator calls and survey
What this could lead to: If successful, this approach could help tailor follow-up care to cancer survivors' needs, potentially improving their quality of life.
What could go wrong: The study was terminated early and enrolled only 5 people, so results are very limited. It is too small to draw any firm conclusions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE I LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STAGE I LUNG CANCER STAGE II LUNG CANCER STAGE III LUNG CANCER STAGE IV LUNG CANCER

Contacts and locations

Show contact details

Locations

Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AH-WFBCCC)

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.